The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenflow Biosci Regulatory News (GENF)

  • This share is currently suspended. It was suspended at a price of 2.05

Share Price Information for Genflow Biosci (GENF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.05
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.05
GENF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NOTIFICATION OF MAJOR HOLDINGS

9 Apr 2024 15:20

RNS Number : 9058J
Genflow Biosciences PLC
09 April 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BP2C3V08

Issuer Name

GENFLOW BIOSCIENCES PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Jonathan Mark Swann

City of registered office (if applicable)

rickmansworth

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

08-Apr-2024

6. Date on which Issuer notified

08-Apr-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.830000

0.000000

4.830000

16874000

Position of previous notification (if applicable)

3.030000

0.000000

3.030000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BP2C3V08

16874000

0

4.830000

0.000000

Sub Total 8.A

16874000

4.830000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

NONE

12. Date of Completion

08-Apr-2024

13. Place Of Completion

london

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALLNEEALEFA
12
Date   Source Headline
1st May 20247:37 amRNSTemporary Suspension
1st May 20247:30 amRNSSuspension - GENFLOW BIOSCIENCES PLC
30th Apr 20247:05 amRNSTotal Voting Rights
10th Apr 20241:32 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Apr 20243:20 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Apr 20242:59 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Apr 20247:00 amRNSSuccessful Placing and Subscription
21st Mar 20247:03 amRNSNOTIFICATION OF MAJOR HOLDINGS
21st Mar 20247:00 amRNSPublication of a Key European Patent
1st Feb 20247:00 amRNSHighlights and Key Priorities
18th Jan 202412:03 pmRNSTwo Non-Dilutive Research Grant Awards
8th Nov 20237:00 amRNSAppointment of Joint Broker
28th Sep 20237:00 amRNSHalf-year Report
20th Sep 20237:00 amRNSCompany Update
13th Jun 20237:00 amRNSAdmittance to trading on the OTCQB Venture Market
8th Jun 202310:54 amRNSResults of Annual General Meeting
16th May 20239:50 amRNSNotice of Annual General Meeting
11th May 20237:00 amRNSAppointment and Internal Restructure
24th Apr 20237:00 amRNSFinal Results
19th Apr 20237:00 amRNSOTCQB Application
4th Apr 20237:00 amRNSCompany Update
22nd Mar 20233:50 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIntellectual property Portfolio addition
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
28th Nov 20224:41 pmRNSSecond Price Monitoring Extn
28th Nov 20224:35 pmRNSPrice Monitoring Extension
28th Nov 20229:06 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
22nd Nov 20224:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20224:35 pmRNSPrice Monitoring Extension
11th Oct 20227:00 amRNSNon-Dilutive Grant Research Award
30th Sep 20227:00 amRNSHalf-year results
15th Aug 20227:00 amRNSCompany Share Purchase by CEO
20th Jul 20227:00 amRNSCompany Share Purchases by Directors
19th Jul 20227:00 amRNSCompany Share Purchase by CEO
29th Jun 20227:03 amRNSBoard Changes
27th Jun 20227:00 amRNSNew Research Agreement
14th Jun 202211:04 amRNSResults of AGM
26th May 20224:40 pmRNSSecond Price Monitoring Extn
26th May 20224:35 pmRNSPrice Monitoring Extension
26th May 20222:05 pmRNSSecond Price Monitoring Extn
26th May 20222:00 pmRNSPrice Monitoring Extension
26th May 202211:05 amRNSSecond Price Monitoring Extn
26th May 202211:00 amRNSPrice Monitoring Extension
25th May 20228:27 amRNSInternational patent application
20th May 20227:05 amRNSNotice of Annual General Meeting
16th May 20227:15 amRNSCompany Update
3rd May 20227:00 amRNSCollaborative Research Agreement with Organips
29th Apr 20227:00 amRNSPosting of Annual Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.